Clinical trial
9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania…
NCT00143182 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00143182 |
|---|---|
| Title | 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED) |
| Official title | A Double-Blind, 9-Week Extension Study Evaluating the Safety and Maintenance of Effect of Asenapine vs. Olanzapine in the Treatment of Subjects With Acute Mania Clinical Trial Protocol A7501006 (Secondary Title: ARES) |
| Lead sponsor | Organon and Co, Industry |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Asenapine, Olanzapine |
| Enrollment | 504 |
| Start date | Jan 7, 2005 |
| Primary completion | Jun 28, 2006 |
| Completion | Jun 28, 2006 |
| First posted | Sep 2, 2005 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: